Generics Industry News Search
 |
|
|
|
|
|
|
March 2014 News Archive |
|
|
| |
|
Shire's patent-infringement lawsuit against Cadila and Zydus over the colitis drug Lialda was reopened, according to court filings...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In a victory of sorts for Hyderabad-based drug company, Natco, the Delhi high court on Friday dismissed a suit filed by Israel-based Teva against the domestic company seeking an injunction over marketing a blockbuster multiple sclerosis medicine, Copaxone, in the US...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Food and Drug Administration has decided to allow generic versions of the most popular form of emergency contraceptive pills to be sold over the counter, without age restrictions, after all...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
French drug maker Sanofi has sued Glenmark over its generic drug filing on cardiac drug Multaq and CNBC-TV18 reports that this suit is an attempt to block entry of cheaper copy-cat versions in the US market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Israeli drug-maker Teva plans to challenge a recent ruling by the Delhi HC that dismissed a suit it filed against India's Natco exporting a blockbuster multiple sclerosis medicine, Copaxone...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IGI Laboratories, a New Jersey based generic topical pharmaceutical company, today announced it has submitted its first ANDA in 2014 to the U.S.FDA...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announces the approval of the generic equivalent to Evista (Raloxifene) tablets, 60 mg, in the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Forest and Adamas announced Forest's submission of a New Drug Application (NDA) to the Food and Drug Administration for a fixed-dose combination of Memantine HCl extended release and Donepezil HCl for the treatment of moderate to severe dementia of the Alzheimer's type...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amarin's lawyers were just in court last week suing the FDA for limiting the exclusivity it granted the drug maker's fish oil pill Vascepa...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
French drug-maker Sanofi filed patent infringement petition against Glenmark on cardiac drug Multaq, in the district court of Delaware, on three counts...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's announced today that it has launched Moxifloxacin hydrochloride tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The US on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on patent...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharma major Lupin announced today that it has received final approval for its Doxycycline capsules ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun Pharmaceuticals, India's biggest drug maker by market value, is looking for partnerships or acquisitions to enter Japan...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announces the launch of the generic equivalent to Xeloda (Capecitabine) tablets, 150 mg and 500 mg, in the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
By the end of 2014, the Greek Ministry of Health aims to raise to at least 30 percent the share of generic drugs in the total volume of prescription drugs sold in Greece...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The largest drugstore chains have been in a legal battle with Pfizer, accusing it of conspiring to keep generics of its antidepressant Effexor XR out of their stores for years...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The FDA declared a Class II recall, which signifies a remote chance of severe adverse consequences or death due to the product flaw...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Apotex must face a Roche lawsuit claiming its generic version of
Valcyte, which treats a virus that afflicts transplant patients and
people with AIDS, infringes a Roche patent that expires in 2015...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
ANI Pharmaceuticals, an emerging generic pharmaceutical company, today announced that it has entered into a fee for service product development agreement for an undisclosed generic drug product with Sterling...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has launched Naloxone hydrochloride injection USP, 0.4 mg/mL packaged in 1 mL single-dose vials...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Indian drugmaker Ranbaxy is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca's heartburn drug Nexium, a source said, to ensure the pills can be sold in the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Medac Pharma, a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announce the issuance, via its parent company,of U.S. patent 8,664,231 from the United States Patent and Trademark Office...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva agreed to pay the U.S. and Illinois $27.6 million to resolve allegations that its units illegally paid a doctor to prescribe a dangerous antipsychotic drug to patients in federal care programs...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has launched, through a distribution and supply agreement, Methazolamide tablets, the generic equivalent to Neptazane tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer confirmed today that the US District Court for the Eastern District of Virginia granted summary judgment invalidating the reissue patent ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amerigen announces that its ANDA for Carbidopa 25mg tablets has received final approval from the U.S.FDA. The product is a generic equivalent of Valeant's Lodosyn...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IGI Laboratories, a New Jersey based generic topical pharmaceutical company, today announced it has received its first approval from the U.S. FDA for an ANDA. The FDA has approved IGI's application for Lidocaine hydrochloride USP 4% topical solution...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Anika Therapeutics, a leader in products for tissue protection, healing and repair, based on hyaluronic acid technology, today announced that Genzyme (plaintiff) and Anika (defendant) filed a joint motion with the U.S. District Court for the District of Massachusetts to lift a stay and dismiss a patent infringement lawsuit concerning Monovisc...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The FDA banned imports from a plant operated by Mumbai-based Sun Pharmaceuticals amid widening scrutiny of Indian drug makers that feed the $93 billion U.S. generics market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today confirmed that the United States District Court for the Eastern District of Virginia has ruled invalid a patent, United States Patent No. RE44,048, related to Pfizer's Celebrex (Celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Eli Lilly has filed a 101-page patent-infringement lawsuit against 35 generic drug companies to block them from selling knockoffs of a Lilly-marketed blood-thinner called Effient...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr Reddy's Laboratories has recalled 58,656 bottles of its heartburn drug Lansoprazole in the United States due to a microbial contamination...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Idenix today announced that it has filed patent infringement lawsuits against Gilead and/or certain of its subsidiaries in each of three countries - France, Germany and the United Kingdom...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer sued Torrent in a bid to block sales of a generic version of erectile-dysfunction drug Viagra while the largest U.S. drugmaker's patent is still in effect...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Natco today announced that it has received tentative approval from the US health regulator to sell generic version of Roche's Tamiflu, used to prevent and treat flu...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
U.S. appeals court upholds finding that Barr did not infringe two Alcon research patents, but reverses finding that alcon's claims were invalid...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today announced that it has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to Actavis' generic version of Daytrana...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A year after hitting the market with a rare disease treatment, Hyperion Therapeutics is facing a challenge from a generic drug maker...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca is staring down the barrel of its Nexium patent loss, but it's doing its best to dodge the bullet. In a bid to keep patients hooked on the branded version of that purple pill, the company will sell Nexium to them directly- and at a discount...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Recent manufacturing problems in India suggest some makers of generic drugs will struggle to compete in the face of a rising quality bar, pointing to a likely a shake-out in the low-cost sector, according to Novartis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin announced today that its US subsidiary has launched its Niacin extended-release tablets USP, 500 mg, 750 mg, 1000 mg strengths having received final approval from the United States Food and Drug Administration yesterday...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
GlaxoSmithKline obtained a preliminary injunction to prevent Sandoz from selling its asthma inhaler AirFluSal Forspiro in Germany, The Wall Street Journal reported Friday...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Intellectual Property Appellate Board has decided to proceed
with the hearing of a revocation petition by Wockhardt against the
patent of a diabetes drug of Swiss pharma major Novartis, even as a
dispute between the parties on an alleged infringement of patent of the
same product is pending with the Delhi High Court...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz announced today that Sandoz Japan has received marketing authorisation approval for its biosimilar filgrastim...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Idenix, today announced that it intends to file an appeal to challenge the Oslo, Norway District Court's decision in a patent invalidity case concerning Idenix's co-owned Norwegian patent NO 330 755 that covers certain 2'-methyl-2'-fluoro nucleoside compounds useful in the treatment of the hepatitis C virus and other flaviviridae infections...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the United States District Court for the Northern District of West Virginia issued a decision upholding the validity of all patents asserted by Mylan, protecting Perforomist (Formoterol fumarate) Inhalation Solution...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Supreme Court on Monday for the second time did not announce whether it would hear an appeal by Teva in a patent fight with generic competitors over a top-selling multiple sclerosis drug...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AMRI today announced that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals for $38.2 million in cash...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
he Food and Drug Administration last week approved Amneal Pharmaceuticals' abbreviated new drug application for Atovaquone oral suspension USP, 750-mg/5-mL...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Food and Drug Administration is about to launch the first generic-drug-testing program in America's history...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A top U.S. regulator is discrediting research published a year ago that found impurities in dozens of generic heart drugs made overseas, saying the investigators contaminated the samples during their testing...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Iroko, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the first patent has been issued by the USPTO for the composition of matter and formulation of Zorvolex (Diclofenac) capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca today announced it has completed the purchase of Sumitomo Chemical's remaining shares in AstraZeneca K.K...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Intellectual Property Appellate Board (IPAB) has issued an interim stay on an order issued by the Indian Patent Office removing a patent of Pfizer, for its extended release drug Detrol...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The department of industrial policy and promotion has shot down a health ministry proposal to consider a government-initiated compulsory licence for cancer drug Dasatinib ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's announced today that it has launched Amlodipine besylate and Atorvastatin calcium tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that, after a trial in the US District Court for the District of New Jersey, a jury returned a verdict in favor of Mylan in its breach of contract lawsuit against GSK ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Synthon today announced that the company's Glatiramer acetate met the main endpoint of a late-stage study in patients with relapsing remitting multiple sclerosis ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sandoz today announced the US launch of Lansoprazole capsules, amoxicillin capsules, USP, and clarithromycin tablets, USP, a generic version of Prevpac...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Delhi High Court has barred the export of generic kidney and liver cancer medication, Sorefenat, on the plea of German drug major Bayer...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The US drug regulator says it has detected no impurity in the Indian version of cholesterol-lowering generic drug Atorvastatin in recent tests...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that the United States Court of Appeals for the Federal Circuit has reversed a lower court ruling that Actavis' generic version of Shire's Lialda (Mesalamine extended-release tablets) infringes United States Patent No. 6,773,720...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Federal Trade Commission seeks a settlement of $1 billion or more from pharmaceutical companies it has sued for delaying the sale of cheaper medicines after patents on brand-name drugs may have expired, an FTC official told a legal conference on Friday...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Supreme Court agreed to hear an appeal by Teva in a move that may delay generic competition to its top-selling Copaxone multiple-sclerosis drug and alter how patent appeals are handled...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva today announced that the U.S. Supreme Court has granted the Company's Copaxone certiorari petition and will hear its appeal of a decision from the United States Court of Appeals for the Federal Circuit that invalidated the claim of U.S. Patent 5,800,808...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Medicines Company Judge Andrews in the U.S. District Court of Delaware issued his Trial Opinion in The Medicines Company v. Hospira...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Eli Lilly today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's favor regarding the vitamin dosage regimen patent for Alimta (Pemetrexed for injection)...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
